Compounds > tosufloxacin
Page last updated: 2024-08-16

tosufloxacin and prulifloxacin

tosufloxacin has been researched along with prulifloxacin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Mitsuhashi, S; Yoshida, T1
Araake, M; Hara, T; Nishino, T; Watabe, H1
Kim, J; Ohtani, H; Sawada, Y; Tsujimoto, M1
Hussain, Z; Li, S; Li, Y; Li, Z; Liu, S; Liu, Y; She, P; Wu, Y; Xu, L; Zeng, X; Zhou, L1

Other Studies

4 other study(ies) available for tosufloxacin and prulifloxacin

ArticleYear
Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:4

    Topics: Anti-Infective Agents; Bacteria; Ciprofloxacin; Dioxolanes; Enoxacin; Fluoroquinolones; Microbial Sensitivity Tests; Mutation; Naphthyridines; Ofloxacin; Piperazines; Quinolones; Topoisomerase II Inhibitors

1993
[In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone].
    The Japanese journal of antibiotics, 2002, Volume: 55, Issue:6

    Topics: Anti-Infective Agents; Ciprofloxacin; Dioxolanes; Dosage Forms; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Fleroxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Naphthyridines; Ofloxacin; Piperazines; Prodrugs; Quinolones

2002
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
    Drug metabolism and pharmacokinetics, 2009, Volume: 24, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Ciprofloxacin; Diclofenac; Dioxolanes; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Male; Mice; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Phenylacetates; Piperazines; Receptors, GABA-A; Seizures

2009
Repurposing Sitafloxacin, Prulifloxacin, Tosufloxacin, and Sisomicin as Antimicrobials Against Biofilm and Persister Cells of Pseudomonas aeruginosa.
    Current microbiology, 2021, Dec-14, Volume: 79, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Dioxolanes; Drug Repositioning; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Sisomicin

2021